Induction of differentiation in embryonic stem cells by 26-kD membrane-bound Tumor Necrosis Factor (TNF) and 17-kD free TNF

In Vivo

Volumn 10, Issue 1, 1996, Pages 19-28

  Kohchi, Chie ^a   Tanabe, Yoshiyuki ^b   Noguchi, Katsuo ^c   Mizuno, Den Ichi ^d   Soma, Gen Ichiro ^c,e  

^a HIROSHIMA UNIVERSITY   (Japan)

^b UNIVERSITY OF SHIZUOKA   (Japan)

^c TAKANO HOSPITAL   (Japan)

^d INSTITUTE OF MICROBIAL CHEMISTRY   (Japan)

^e ST MARIANNA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Differentiation; Embryonic stem cells; Tumor necrosis factor

Indexed keywords

TUMOR NECROSIS FACTOR;

ANIMAL CELL; ARTICLE; CELL CONTACT; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL STRAIN 3T3; CONTROLLED STUDY; EMBRYO; EMBRYO DEVELOPMENT; MEMBRANE BINDING; MOUSE; NONHUMAN; STEM CELL;

EID: 0029938273     PISSN: 0258851X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (45)

1. Mizuno D and Soma G: Endogenous and exogenous TNF therapy (EET therapy): conceptual and experimental grounds. Ann Inst Pasteur/Immunol 139: 282-285, 1988.
2. Kohchi C, Noguchi K, Tanabe Y, Mizuno D and Soma G-I: Constitutive expression of TNF-α and -β genes in mouse embryo: roles of cytokines as regulator and effector on development. Int J Biochem 26: 111-119, 1994.
3. Kohchi C, Mizuno D and Soma G-I: Expression of tumor necrosis factor-α and -β transcripts in embryonal carcinoma and trophoblast cell lines: inflammation-like state as possible regulatory mechanism for ontogenesis. Eur Cytokine Net 2: 245-255, 1991.
4. Old LJ: Tumor necrosis factor: Polypeptide mediator network. Nature 326: 330-331, 1987.
5. Sugarman BJ, Aggarwal BB, Hass PE, Figari IS, Palladino MA and Shepard HM: Recombinant human tumor necrosis factor-α: effects on proliferation of normal and transformed cells in vitro. Science 230: 943-945, 1985.
6. Takeda K, Iwamoto S, Sugimoto H, Takuma T, Kawatani N, Noda M, Masaki A, Morise H, Arimura H and Konno K: Identity of differentiation inducing factor and tumour necrosis factor. Nature 323: 338-340, 1986.
7. Elias L, Moore PB and Rose SM: Tumor necrosis factor induced DNA fragmentation of HL-60 cells. Biochem Biophys Res Commun 157: 963-969, 1988.
8. Laster SM, Wood JG and Gooding LR: Tumor necrosis factor can induce both apoptic and nccrotic forms of cell lysis. J Immunol 141: 2629-2634, 1988.
9. Robaye B, Mosselmans R, Fiers W, Dumont JE and Galand P: Tumor necrosis factor induces apoptosis (programmed cell death) in normal endothelial cells in vitro. Am J Pathol 138: 447-453, 1991.
10. Wright SC, Kumar P, Tam AW, Shen N, Varma M and Larrick JW: Apoptosis and DNA fragmentation precede TNF-induced cytolysis in U937 cells. J Cell Biochem 48: 344-355, 1992.
11. Zuniga-Pflucker JC, Jiang D and Lenardo MJ: Requirement for TNF-α and IL-1α in fetal thymocyte commitment and differentiation. Science 268: 1906-1909, 1995.
12. Muller R, Marmenout A and Fiers W: Synthesis and maturation of recombinant human tumor necrosis factor in eukaryotic systems. Fed Eur Biochem Sci 197: 99-104, 1986.
13. Pennica R, Nedwin GE, Hayflick JS, Seeburg PH, Derynck R, Palladino MA, Kohr, WJ, Aggarwal BB and Goeddel DV: Human tumour necrosis factor: precursor, structure, expression and homology to lymphotoxin. Nature 312: 724-729, 1984.
14. Kinkhabwala M, Sehajpal P, Skolnik E, Smith D, Sharma VK, Vlassara H, Cerami A and Suthanthiran M: A novel addition to the T cell repertory: Cell surface expression of tumor necrosis factor/cachectin by activated normal human T cells. J Exp Med 171: 941-946, 1990.
15. Nii A, Sone S, Orino E and Ogura T: Induction of a 26-kDa membrane-form tumor necrosis factor (TNF)-α in human alveolar macrophages. J Leukocyte Biol 53: 29-36, 1993.
16. Kriegler M, Perez C, DeFay K, Albert I and Lu SD: A novel form of TNF/cachectin is a cell surface cytotoxic transmembrane protein: ramifications for the complex physiology of TNF. Cell 53: 45-53, 1988.
17. Liu CC, Detmers PA, Jiang S and Young JDE: Identification and characterization of a membrane-bound cytotoxin of murine cytolytic lymphocytes that is related to tumor necrosis factor /cachectin. Proc Natl Acad Sci USA 86: 3286-3290, 1989.
18. Decker T, Lohmann-Matthes ML and Gifford GE: Cell-associated tumor necrosis factor (TNF) as a killing mechanism of activated cytotoxic macrophages. J Immunol 138: 957-962, 1987.
19. Nakabo Y, Harakawa N, Yamamoto K, Okuma M, Uno K and Sasada M: Leukemic cell lysis by activated human macrophages: significance of membrane-associated tumor necrosis factor. Jpn J Cancer Res 84: 1174-1180, 1993.
20. Perez C, Albert I, DeFay K, Zachariades N, Gooding L and Kriegler M: A nonseeretable cell surface mutant of tumor necrosis factor (TNF) kills by cell-to-cell contact. Cell 63: 251-258, 1990.
21. Aversa G, Punnonen J and de Vries, JE: The 26-kD transmembrane form of tumor necrosis factor α on activated CD4+T cell clones provides a costimulatory signal for human B cell activation. J Exp Med 177: 1575-1585, 1993.
22. Tanabe Y, Kitahara-Tanabe N, Mizuno D and Soma G: Regulation of enhanced production of tumor necrosis factor α (TNF α) by its precursor on the cell-surface of primed macrophage. Cytokine 6: 337-348, 1994.
23. Yamasu K, Onoe H, Soma G, Oshima H and Mizuno D: Secretion of tumor necrosis factor during fetal and neonatal development of the mouse: ontogenic inflammation. J Biol Resp Mod 8: 644-655, 1989.
24. Ohsawa T and Natori S: Expression of tumor necrosis factor at a specific developmental stage of mouse embryos. Dev Biol 135: 459-461, 1989.
25. Kawase E, Suemori H, Takahashi N, Okazaki K, Hashimoto K and Nakatsuji N: Strain difference in establishment of mouse embryonic stem (ES) cell lines. Int J Dev Biol 38: 385-390, 1994.
26. Robertson EJ: Embryo-derived stem cell lines. In: Teratocarcinomas and Embryonic Stem Cells. A Practical Approach (Robertson EJ, Ed). Oxford, Washington DC, IRL Press, 1987, pp. 71-112.
27. Ginsburg M, Snow MHL and McLaren A: Primordial germ cells in the mouse embryo during gastrulation. Development 100: 521-528, 1990.
28. Kaufman RJ, Davies MV, Pathak V and Hershey JWB: The phosphorylation state of eucaryotic initiation factor 2 alters translational efficiency of specific mRNAs'. Mol Cell Biol 9: 946-958, 1989.
29. Felgner PL, Gadek TR, Holm M, Roman R, Chan HW, Wenz M, Northrop JP, Ringold GM and Danielsen M: Lipofection: a highly efficient, lipid-mediated DNA-transfection procedure. Proc Natl Acad Sci USA 84: 7413-7417, 1987.
30. Chomczynski P and Sacchi N: Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162: 156-159, 1987.
31. Ruff MR and Gifford GE: Tumor necrosis factor. Lymphokines 2: 235-272, 1980.
32. Wride MA and Sanders EJ: Expression of tumor necrosis factor-α (TNFα)-cross-reactive proteins during early chick embryo development. Dev Dynamics 198: 225-239, 1993.
33. Pampfer S, Wuu YD, Vanderheyden I and de Hertogh R: Expression of tumor necrosis factor-α (TNFα) receptors and selective effect of TNFα on the inner cell mass in mouse blastocysts. Endocrinol 134: 206-212, 1994.
34. Kawase E, Yamamoto H, Hashimoto K and Nakatuji N: Tumor necrosis factor-α (TNF-α) stimulates proliferation of mouse primordial germ cells in culture. Dev Biol 161: 91-95, 1994.
35. Pfeffer K, Matsuyama T, Kundig TM, Wakeham A, Kishihara K, Shahinian A, Wiegmann K, Ohashi PS, Kronke M and Mak TW: Mice deficient for the 55-kD tumor necrosis factor receptor are resistant to endotoxic shock, yet succumb to L. monocytogenes infection. Cell 73: 457-467, 1993.
36. Rothe J, Lesslauer W, Lotscher H, Lang Y, Koebel P, Kontgen F, Althage A, Zinkernagel R, Steinmetz M and Bluethmann H: Mice lacking the tumour necrosis factor receptor 1 are resistant to TNF-mediated toxicity but highly susceptible to infection by Listeria monocytosenes. Nature 36: 798-802, 1993.
37. Yamamoto R, Taniguchi T, Kudara E, Matsubara Y, Imamura K, Gotoh S, Fukuda K and Sekikawa K: Generation of mice disrupted TNFα gene. Proceedings of the 16th Annual Meeting of the Japanese Society of Molecular Biology, pp213, 1993.
38. Paul NL and Ruddle NH: Lymphotoxin. Ann Rev Immunol 6: 407-438, 1988.
39. Browning JL, Ngam-ek A, Lawton P, DeMarinis J, Tizard R, Chow EP, Hession C, O'Brine-Greco B, Foley SF and Ware CF: Lymphotoxin β, a novel member of the TNF family that forms a heteromeric complex with lymphotoxin on the cell surface. Cell 72: 847-856, 1993.
40. Goodwin RG, Alderson MR, Smith CA, Armitage RJ, Van-denBos T, Jerzy R, Tough TW, Schoenborn MA, Davis-Smith T, Hennen K, Falk B, Cosman D, Baker E, Sutherland GR, Grabstein KH, Farrah T, Giri JG and Beckmann MP: Molecular and biological characterization of ligand for CD27 defines a new family of cytokines with homology to tumor necrosis factor. Cell 73: 447-456, 1993.
41. Smith CA, Gruss HJ, Davis T, Anderson D, Farrah T, Baker E, Sutherland GR, Brannan CI, Copeland NG, Jenkins NA, Grabstein KH, Gliniak B, McAlister IB, Fanslow W, Alderson M, Falk B, Gimpel S, Din WS, Goodwin RG and Armitage RJ: CD30 antigen, a marker for Hodgkin's lymphoma, is a receptor whose ligand defines an emerging family of cytokines with homology to TNF. Cell 73: 1349-1360, 1993.
42. Armitage RJ, Fanslow WC, Strockbine L, Sato TA, Clifford KN, Macduff BM, Anderson DM, Gimpel SD, Davis-Smith T, Maliszewski CR, Clark EA, Smith CA, Grabstein KH, Cosman D and Spriggs MK: Molecular and biological characterization of murine ligand for CD40. Nature 357: 80-82, 1992.
43. Suda T, Takahashi T, Golstein P and Nagata S: Molecular cloning and expression of the Fas ligand, a novel member of the tumor necrosis factor family. Cell 75: 1169-1178, 1993.
44. Mizuno D and Soma G: Oral or percutaneous administration of lipopolysaccharide of small molecular size may cure various intractable diseases: a new version of Coley's toxin. Mol Biother 4: 166-169, 1992.
45. Flesch IEA, Hess JH, Huang S, Aguet M, Rothe J, Bluethmann H and Kaufmann SHE: Early interleukin 12 production by macrophages in response to mycobacterial infection depends on interferon y and tumor necrosis factor α. J Exp Med 181: 1615-1621, 1995.